Elevance Health (ELV) is a publicly traded Healthcare sector company. As of August 18, 2026, ELV trades at $397.55 with a market cap of $86.82B and a P/E ratio of 16.53. ELV moved +2.02% today. Year to date, ELV is +11.32%; over the trailing twelve months it is +26.06%. Its 52-week range spans $273.71 to $458.75. Analyst consensus is buy with an average price target of $449.33. Rallies surfaces ELV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Elevance Health (ELV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ELV moved +2.02% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $397.55 |
| Market Cap | $86.82B |
| P/E Ratio | 16.53 |
| EPS | $23.64 |
| Dividend Yield | 1.72% |
| 52-Week High | $458.75 |
| 52-Week Low | $273.71 |
| Volume | 235.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $200.41B |
| Net Income | $5.24B |
| Gross Margin | 89.19% |
19 analysts cover ELV: 0 strong buy, 13 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $449.33.